Scientific news

Rothman Institute in Philadelphia will study medical marijuana for pain relief

The Rothman Institute at Jefferson, one of the nation’s largest orthopedic practices, announced Thursday it would collaborate on a study to investigate the benefits of medical marijuana for patients suffering from chronic and acute pain.

Cannabis associated with immune cell frequency reduction in ART-treated HIV patients

A recent study found that cannabis use is associated with a potentially beneficial reduction in systemic inflammation and immune activation in the context of antiretroviral therapy (ART)-treated HIV-infected individuals.

Medical cannabis safer for elderly with chronic pain than opioids

A new study found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, ulcerative colitis, and other medical issues. After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.

Could we beat the opioid epidemic by easing pain with marijuana?

The number of Americans touched by the opioid epidemic has reached alarming proportions. But there may be a less-risky alternative to opioids for alleviating certain types of chronic pain: marijuana.

Cannabinoids are easier on the brain than booze, study finds

Marijuana may not be as damaging to the brain as previously thought, according to new research from the University of Colorado Boulder and the CU Change Lab.

Emerald Health shares data of patented cannabinoid against Parkinson's disease

A division of Emerald Health Therapeutics announced key members of its scientific team found the potential for a cannabigerol (CBG) derivative to treat Parkinson's disease.

World-first medicinal cannabis trial for Queensland palliative care patients receives funding

A world-first trial has received federal funding and within a matter of months, Queensland researchers hope to start investigating the symptom relief medicinal cannabis can provide to cancer patients receiving palliative care.

'Pharma-Grade' CBD effective in Lennox-Gastaut syndrome

Adding a purified formulation of cannabidiol (CBD; Epidiolex, GW Pharmaceuticals) to standard anticonvulsant therapy significantly reduces the number of drop seizures in children with Lennox-Gastaut syndrome, results of a phase 3 randomized, double-blind, placebo-controlled clinical trial show.

Developing a roadside test for marijuana intoxication isn't as easy as it sounds

Recent studies have identified new biomarkers that can be used to estimate a person's recent cannabinoid intake. But, using those markers to judge cognitive and behavioral impairment is complex, say toxicologists.

Cannabinoid may be first drug for sleep apnea

Dronabinol, a synthetic form of the cannabis compound tetrahydrocannabinol (THC), shows efficacy in the treatment of obstructive sleep apnea, possibly representing a first pharmacologic approach to the tough-to-treat, but potentially serious, condition.